CSF2 and nosocomial infection: While we have previously shown that treatment with GM-CSF can reverse TBI/H-induced systemic immunosuppression, the presented experiments represent the first evidence that treatment with GM-CSF can reduce lung bacterial load in an experimental model of nosocomial infection after traumatic injury.